LV.4 MIDTERM COMPRE 2ND SEM MOCK

• • GET OUT OF HERE! > V ERBALLY A CKNOWLEDGE
• • PNEUMONIA > SPUTUM > A NTIBIOTIC
• • TB > N 95 RESPIRATOR MASK > STAFF AND VISITORS
• • (+) TUBERCULIN TEST > RIE > PREGNANT > TAKEN SINCE UNTREATED PRESENTS FAR GREATER HAZARD TO MOTHER & FETUS THAN TREATMENT
• • NORMAL / HEALTHY > 5 MM SKIN INDURATION > NEGATIVE
• • TB 2 AIDS > A IRBORNE PRECAUTION
• • RECURRENT UTI > ELIMINATE C AFFEINE & T EA
• • UTI > NITROFURANTOIN (FURADANTIN) > D ISCOLORS URINE TO B ROWN > CONTINUE
• • UTI > P.O SULFAMETHOXAZOLE (GANTANOL) > NEAR TERM P REGNANCY> NOTIFY HCP
• UTI > CIPROFOLOXACIN (CIPRO-XR)

  1. AVOID WITH M ILK OR Y OGURT > DECREASE ABSORPTION
  2. FALSE POSITIVE RESULT> DRUG/ OPIOIDS SCREENING TEST > F LUROQUINOLONES
• • HAND INJURY FROM N AIL GUN WHILE REMODELING O LD BARN > DATE OF LAST T ETANUS IMMUNIZATION
• • T ETANUS VACCINATION > ARTIFICIAL ACTIVE IMMUNITY > INJECT T ETANUS > BODY BUILD ANTI GEN
• FLU VS. COVID - 19

  1. P CR TEST
  2. S ARS - COV- 2 & INFLUENZA
• COVID - 19

  1. VIRAL TEST > IDENTIFY S ARS-COV-2
  2. GOLD STANDARD > P CR TEST > RESULT IN 3 DAYS
  3. ANTIGEN TEST > LESS ACCURATE > 2 NEGATIVE RESULT BY FDA
  4. MRNA VACCINE > INSTRUCT TO PRODUCE P ROTEIN > TRIGGER I MMUNE RESPONSE > D ON'T INTERACT OR AFFECT HUMAN DNA
• IMCI

  1. PRIMARY GOAL: R EDUCE PREVENTABLE M ORTALITY AND M INIMIZE ILLNESS AND D ISABILITY IN CHILDREN UNDER F IVE
  2. BETTER THAN SINGLE CONDITION APPROACH > H OLISTIC ASSESSMENT AND TREATMENT OF M ULTIPLE CONDITION
  3. KEY REQUIREMENTS: AVAILABILITY OF M EDICINE L ABORATORY TEST AND E QUIPMENT
  4. IMPROVED CARE OF SEVERELY ILL: SPEED UP R EFERRALS TO S PECIALIZED HOSPITAL
• HIV

  1. V IROLOGICAL TEST DETECT HIV INFECTION> CHILDREN > A NY AGE INCLUDING BEFORE 18 MONTHS
  2. (-) TEST > B REASTFEEDING CHILD > NOT RULE OUT > ANTI BODIES FROM MOTHER MAY STILL BE PRESENT
  3. A NTIBODY TEST > DETECT ANTIBODY MADE BY IMMUNE TO RESPONSE TO VIRUS
  4. CHILD WITH CONFIRMED S YMPTOMATIC HIV INFECTION > ADMINISTER C OTRIMOXAZOLE P ROPHYLAXIS
  5. VIT. A > EVERY 6 MONTHS STARTING AT 6 MONTHS
  6. PNEUMONIA > C OTRIMOXAZOLE P ROPHYLAXIS > ORAL A MOXICILLIN
• CF

  1. 17 Y/O LEAVING HOME FOR COLLEGE > NEEDS FURTHER TEACHING > E XTRA C OUGH MED NOT TO WAKE UP ROOMATE AT NIGHT
  2. PANCRELIPASE (PANCREASE) > I MPROVED N UTRITIONAL STATUS
  3. ABN ACCUMULATION OF M UCUS > MANAGE I NFECTION
  4. NEEDS FURTHER TEACHING > NO P ANCREATIC E NZYME SUPPLEMENTS WILL BE NECESSARY IF WITH GOOD A PPETITE & REGULAR B OWEL M OVEMENTS
• SICKLE CELL ANEMIA

  1. LOWEST RISK FOR PRENATAL SICKLE CELL DSE. & THALASSEMIA > S CANDINAVIAN
  2. POST-OP C HX OF SICKLE CELL DSE. > IN EFFECTIVE AIRWAY C LEARANCE
  3. VASO-OCCLUSIVE PAIN > LARGE AMOUNTS OF F LUID DAILY
  4. CHILD > DX: SICKLE CELL DSE. > S/P: SPLENECTOMY > ALLERGIC TO PENICILLIN > DISCHARGE > E RYTHROMYCIN ETHYLSUCCINATE (ERYPED)
• RAI

  1. FEMALE > THOUGH NOT PREGNANT USE C ONTRACEPTIVES OR A BSTAIN > POSTPONE UNTIL 6 MONTHS OFF MED
  2. (+) COPING > "I SELECTED WIG THAT MATCHES HAIR"
• FLUID VOLUME DEFICIT

  • DRY MUCUS MEMBRANES AND POOR SKIN TURGOR
• FLUID VOLUME EXCESS

  • A SCITES
• S TERCOBILIN

  • BROWN COLOR OF STOOL
• BLACK COLOR

  • UGIB
• GI O BSTRUCTION

  • NARROW PENCIL SHAPED STOOL
• 24 HRS. POST-ABDOMINOPLEVIC > BLADDER S PASMS >5/10 ABDOMINAL PAIN > B ELLADONNA AND OPIUM S UPPOSITORY > INHIBIT SMOOTH M USCLE C ONTRACTION
• ADMINISTER 1ST> NITROGLYCERIN S UBLINGUAL S TAT > CHEST PAIN
• BEFORE REMOVE CHEST TUBE > ADMINISTER 4 MG M ORPHINE SULFATE INTRA VENOUSLY > PEAK ACTION
• ELDERLY C DEMENTIA > PACU > S/P HIP HEMIARTHROPLASTY > PAIN > S CHEDULED DOSES OF M ORPHINE SULFATE IV ATC
• • 2ND TRIMESTER > REWRITTEN > M GSO4 5G INTRA MUSCULAR IF BP 160 / 90 MMHG X 2 READINGS
• CYCLOBENZAPRINE 30 MG P.O TID > C ALL H CP TO QUESTION ORDER > 60 MG
• EXPERIENCED NURSE INTERVENE IN NEW RN > WITHDRAW 1ML PPD > O.1 ML
• FUNDUS FEEL SOFT & SPONGY > M ASSAGE AND OBSERVE INCREASED V AGINAL B LEEDING OR C LOTS
• UHC ( RA 11223)

  1. NOT POTENTIAL OBSTACLE > ENTITLE FILIPINO COST LESS > P RIVATIZATION OF HEALTHCARE SERVICES
  2. SUSTAINABLE FUNDING MECHANISM > IMPLEMENTING I NSURANCE PREMIUMS
  3. COLLABORATION AMON STAKEHOLDERS > E QUITABLE RESOURCE DISTRIBUTION
  4. PREVENTIVE HEALTHCARE SERVICES > REDUCING NON-COMMUNICABLE DSE. BURDEN
  5. RANGE OF HEALTH SERVICE > PRO MOTIVE, PRE VENTATIVE, CU RATIVE, RE HABILITATIVE & PA LLIATIVE
  6. ENROLLED > A UTOMATIC > D IRECT / IN DIRECT CONTRIBUTION
  7. 1ST CONTACT FOR HEALTH CONCERN > HCP
  8. ESSENTIAL HEALTH BENEFIT PACKAGE > M EDICINE, D IAGNOSTIC AND P RIMARY CARE
  9. CO-PAYMENT > DOH
• M ENTAL HEALTH ACT ( RA 11036)

  1. (SEC. 2) OBJECTIVE: PROMOTE M ENTAL HEALTH & A CCESS
  2. DE INSTITUTIONALIZATION : TRANSITIONING FROM I NSTITUITION TO C OMMUNITY BASED SETTINGS
  3. RECOVERY BASED APPROACH: INVOLVE P ARTICIPATION
  4. PSYCHIATRIC OR N EUROLOGIC E MERGENCY : SERIOUS THREAT TO ALL (I.E. SELF) AND IMMEDIATE MEDICAL INTERVENTION
• INFORMATICS

  1. EB > L ATEST RESEARCH AND B EST PRACTICE
  2. EB > PT. SAFETY > G UIDE IMPLEMENTATION C P ROVEN EFFECTIVENESS
  3. EHR > IMPROVED A CCURACY OF PT. R ECORDS
  4. MOBILE HEALTH APP MONITOR DISCHARGE > REDUCED RE ADMISSION
  5. B ARCODE MEDICATION > REDUCE MEDICATION ERRORS
  6. REMOTE PT. MONITORING SYSTEM > T IMELY INTERVENTION
  7. PT. CENTERED CARE > CONSIDER U NIQUE NEEDS & PREFERENCES ; INVOLVE END-USERS
• NAEGELE'S RULE

  1. January to March = +9+7
  2. April to December = -3 +7 + 1
• MGSO4 > PREECLAMPSIA > Q 30 MIN >IMMEDIATELY CONTACT HCP > RR 10 B REATHS / MIN.
• IUF D EMISE

  • REGRESSION OF PREGNANCY SYMPTOMS & ABSENCE OF F HEART TONE
• PLACENTAL DELIVERY

  • INSTRUCT TO P USH D URING CONTRACTIONS
• L ACK OF K NOWLEDGE

  • WORRIED ABOUT HOW TO CARE FOR F IRST B ORN CHILD